Niox Group (NIOX)

Sector:

Health Care

Index:

FTSE AIM 50

65.00p
   
  • Change Today:
    -2.80p
  • 52 Week High: 76.00
  • 52 Week Low: 54.60
  • Currency: UK Pounds
  • Shares Issued: 399.36m
  • Volume: 369,251
  • Market Cap: £259.58m
  • Beta: 0.01

Niox Group Overview

Niox Group is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a 2.4
Op Mrgn 18.4% 23.0%
ROCE 21.4%  
Latest F'cast
P/E 28.6 24.1
PEG n/a 1.3
Pr/Revenue 6.2 5.5
Pr/Book 4.4  
Latest F'cast
Revenue 13.6% 12.7%
PBT 90.2% 39.2%
EPS -41.3% 18.8%
DPS n/a n/a

Niox Group Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 23.90 (18.40) (7.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 27.90 (2.10) 0.55p 73.8 n/a n/a n/a 0.0%
31-Dec-22 31.30 10.50 2.73p 13.4 0.0 +396% n/a 0.0%
31-Dec-23 36.80 4.10 3.87p 17.3 0.4 +42% n/a 0.0%
31-Dec-24 41.80 7.80 2.27p 27.8 n/a -41% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Niox Group Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 47.11 10.85 2.70p 24.1 1.3 +19% 1.12p 0.0%
31-Dec-26 52.37 13.06 3.23p 20.1 1.0 +20% 1.23p 0.0%
31-Dec-27 58.04 15.48 3.83p 17.0 0.9 +18% 1.47p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Niox Group Company Announcements

Block Listing Application 21-May-2025 17:15 RNS
Holding(s) in Company 21-May-2025 17:15 RNS
Holding(s) in Company 21-May-2025 17:00 RNS

Niox Group ShareCast News

Niox Group reports strong start to 2025 14-May-2025 ShareCast
Niox ends sale process as Keensight steps back 11-Apr-2025 ShareCast
Niox reports solid set of full-year results 01-Apr-2025 ShareCast

Niox Group Top Newspaper Links

Circassia raises £200m in landmark biotech IPO 14-Mar-2014 The Independent
Cat allergy group raises £200m in float 14-Mar-2014 Telegraph

Latest Niox Group Director Deals

Traded Action Notifier PriceAmountValue
20-May-25 Sell Jonathan Emms 65.00p 2,745,925 £1,784,851.18
20-May-25 Sell Ian Johnson 65.00p 3,924,630 £2,551,009.41
20-May-25 Exercise of option Jonathan Emms 0.080p 4,940,202 £3,952.16

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Niox Group Market Data

Currency UK Pounds
Share Price 65.00p
Change Today -2.80p
% Change -4.13 %
52 Week High 76.00
52 Week Low 54.60
Volume 369,251
Shares Issued 399.36m
Market Cap £259.58m
Beta 0.01

Niox Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
89.8% below the market average89.8% below the market average89.8% below the market average89.8% below the market average89.8% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average
Price Trend
33.29% above the market average33.29% above the market average33.29% above the market average33.29% above the market average33.29% above the market average
62.16% above the sector average62.16% above the sector average62.16% above the sector average62.16% above the sector average62.16% above the sector average
Income
83.08% below the market average83.08% below the market average83.08% below the market average83.08% below the market average83.08% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Growth
35.16% above the market average35.16% above the market average35.16% above the market average35.16% above the market average35.16% above the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Niox Group Dividends

  Latest Previous
  Final Final
Ex-Div 15-May-25 23-May-24
Paid 16-Jun-25 24-Jun-24
Amount 1.25p 1.00p

Trades for 21-May-2025

Time Volume / Share Price
16:38 25,000 @ 65.15p
16:35 3,318 @ 65.00p
16:35 652 @ 65.00p
16:35 629 @ 65.00p
16:35 897 @ 65.00p

Niox Group Key Personnel

CEO Jonathan Emms

Top of Page